Deborah A. Elman

  • Title: Director
  • Phone: (646) 722-8534
  • Email:
  • Education:

    University of Pittsburgh School of Law, J.D., cum laude (2001)

    Columbia University, M.P.H. (1997)

    Columbia University, B.A., cum laude (1995)

  • Admissions:
    New York, Pennsylvania, U.S. Court of Appeals for the 2nd Circuit, U.S. Court of Appeals for the 3rd Circuit, U.S. Court of Appeals for the 9th Circuit, U.S. District Court for the Southern District of NY, U.S. District Court for the Eastern District of NY, U.S. District Court for the Western District of PA, U.S. District Court for the Northern District of IL

Deborah Elman is a director at Grant & Eisenhofer, where she has nearly two decades experience representing both plaintiffs and defendants in high-profile  antitrust and securities litigation, with a particular focus litigating claims in the pharmaceutical, financial services, and commodities industries. She has represented institutional clients and individuals in an array of complex civil litigation cases, including class actions, opt-outs, derivative actions, and arbitrations. Ms. Elman is also Co-Director of the Grant & Eisenhofer ESG Institute.

Currently, Ms. Elman serves as co-lead counsel in several cases, including In re Payment Card Interchange Fee & Merchant Discount Antitrust Litigation, In re London Silver Fixing, Ltd. Antitrust Litigation, and In re Keurig Green Mountain Single-Serve Coffee Antitrust Litigation. She is a member of the Executive Committee in In Re: Humira (Adalimumab) Antitrust Litigation, and class counsel in In re Generic Pharmaceuticals Pricing Antitrust Litigation, In re Novartis and Par Antitrust Litigation (Exforge), In re Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation,  In re Foreign Exchange Benchmark Rates Antitrust Litigation (“FOREX”), In re Broiler Chicken Antitrust Litigation, In re Pork Antitrust Litigation, and In re Diisocyanates Antitrust Litigation, among others.

Ms. Elman litigated and settled numerous cases related to the financial crisis, including more than fifteen actions arising out of wrongdoing involving the issuance of residential mortgage-backed securities (“RMBS”) and other complex financial products, and was class counsel in Alaska Electrical Pension Fund v. Bank of America Corporation et al. (“ISDAFix”).  Additionally, Ms. Elman was a member of the litigation teams that successfully represented the lead plaintiff in a case dubbed “The Enron of India,” In re Satyam Computer Services Ltd. Securities Litigation, which settled for $150.5 million, and In re Kinder Morgan Energy Partners, L.P. Derivative Litigation, which settled for $27.5 million. She represented institutional investors in In re Merck and Co., Inc. Securities, Derivative & ERISA Litigation and In re Petrobras Securities Litigation, resulting in substantial investor recoveries.

Prior to joining Grant & Eisenhofer, Ms. Elman represented clients before the SEC, DOJ, and state regulators, and participated in numerous appearances before federal and state courts as an associate at a leading New York law firm.

Ms. Elman served as a law clerk for the Honorable William L. Standish, United States District Judge, in the United States District Court for the Western District of Pennsylvania, participating in all aspects of federal trial court practice.

Ms. Elman graduated cum laude in 2001 from the University of Pittsburgh School of Law, where she was Lead Executive Editor of the Journal of Law and Commerce. She received a Masters of Public Health degree in 1997 from Columbia University, where she also graduated cum laude with a Bachelor of Arts degree in 1995.